CCA
GILD icon

Childress Capital Advisors’s Gilead Sciences GILD Stock Holding History

Childress Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Sell
13,874
-1,695
-11% -$223K 0.29% 58
2026
Q1 		$2.17M Sell
15,569
-367
-2% -$51.4K 0.39% 42
2025
Q4 		$1.96M Buy
15,936
+3,172
+25% +$385K 0.31% 51
2025
Q3 		$1.42M Buy
12,764
+5,190
+69% +$590K 0.26% 63
2025
Q2 		$840K Buy
7,574
+1,914
+34% +$204K 0.21% 77
2025
Q1 		$634K Buy
5,660
+112
+2% +$11.6K 0.18% 80
2024
Q4 		$512K Buy
5,548
+79
+1% +$7.11K 0.14% 99
2024
Q3 		$459K Sell
5,469
-292
-5% -$22.3K 0.12% 122
2024
Q2 		$395K Buy
5,761
+1,507
+35% +$101K 0.11% 125
2024
Q1 		$312K Sell
4,254
-865
-17% -$66.5K 0.09% 145
2023
Q4 		$415K Buy
5,119
+1,077
+27% +$83.8K 0.12% 106
2023
Q3 		$303K Buy
+4,042
New +$311K 0.1% 122
2023
Q1 		– Sell
-5,155
Closed -$443K – 121
2022
Q4 		$443K Sell
5,155
-856
-14% -$67.8K 0.15% 103
2022
Q3 		$375K Buy
6,011
+1,940
+48% +$122K 0.15% 101
2022
Q2 		$252K Buy
4,071
+259
+7% +$16K 0.1% 136
2022
Q1 		$226K Sell
3,812
-1,089
-22% -$69.6K 0.08% 169
2021
Q4 		$356K Sell
4,901
-1,383
-22% -$95.3K 0.15% 116
2021
Q3 		$438K Buy
6,284
+2,943
+88% +$207K 0.18% 104
2021
Q2 		$230K Sell
3,341
-2,584
-44% -$173K 0.1% 145
2021
Q1 		$382K Buy
5,925
+1,668
+39% +$108K 0.18% 109
2020
Q4 		$248K Buy
+4,257
New +$257K 0.14% 82

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Childress Capital Advisors's GILD Position: Q2 2026 in Review

Childress Capital Advisors reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $223K and leaving 13,874 shares worth $1.75M. The position accounts for 0.29% of the portfolio, ranked #58.

Childress Capital Advisors first reported a position in GILD in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.17M in Q1 2026. 2,282 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Childress Capital Advisors held 13,874 shares of Gilead Sciences worth $1.75M as of Q2 2026.
  • Childress Capital Advisors sold 1,695 Gilead Sciences shares in Q2 2026, an estimated $223K.
  • Gilead Sciences made up 0.29% of Childress Capital Advisors's portfolio in Q2 2026, its #58 holding.
  • Childress Capital Advisors first reported a position in Gilead Sciences in Q4 2020 and has held it in 21 quarters since.
  • Childress Capital Advisors's Gilead Sciences position peaked at $2.17M in Q1 2026.
  • 2,282 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.